nuvasive® is a place where we create new and innovative products at a speed that drives our ability to deliver absolute responsiveness®, and gives us a competitive edge. at nuvasive, we empower our shareowners to influence results and significantly contribute to the success of the company. together we make nuvasive a leader in the spine industry with our unique focus on speed of innovation®. every member of the nuvasive family has the opportunity to improve the lives of patients through their work. these life-changing career paths show how hard work, a competitive spirit and your unwavering dedication to the patient can take you and your career to new places. in addition to being a great place to have a career, we’re also committed to giving back and supporting our communities. through an attitude of gratitude, nuvasive provides life-changing spinal surgery to disadvantaged communities through our nonprofit, the nuvasive spine foundation®, and offers patient-to-patient support through
Company profile
Ticker
NUVA
Exchange
Website
CEO
J. Christopher Barry
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
NuVasive Specialized Orthopedics, Inc. • NuVasive Clinical Services Monitoring, Inc. • NuVasive Technology International Limited ...
IRS number
330768598
NUVA stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
11 Sep 23
EFFECT
Notice of effectiveness
8 Sep 23
EFFECT
Notice of effectiveness
8 Sep 23
EFFECT
Notice of effectiveness
8 Sep 23
EFFECT
Notice of effectiveness
8 Sep 23
EFFECT
Notice of effectiveness
8 Sep 23
EFFECT
Notice of effectiveness
8 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Sep 23
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Sep 23
Transcripts
NUVA
Earnings call transcript
2023 Q2
2 Aug 23
NUVA
Earnings call transcript
2023 Q1
10 May 23
NUVA
Earnings call transcript
2022 Q4
22 Feb 23
NUVA
Earnings call transcript
2022 Q3
10 Nov 22
NUVA
Earnings call transcript
2022 Q2
4 Aug 22
NUVA
Earnings call transcript
2022 Q1
5 May 22
NUVA
Earnings call transcript
2021 Q4
24 Feb 22
NUVA
Earnings call transcript
2021 Q3
10 Nov 21
NUVA
Earnings call transcript
2021 Q2
29 Jul 21
NUVA
Earnings call transcript
2021 Q1
6 May 21
Latest ownership filings
Financial summary
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 82.21 mm | 82.21 mm | 82.21 mm | 82.21 mm | 82.21 mm | 82.21 mm |
Cash burn (monthly) | 33.49 mm | 12.11 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 527.69 mm | 190.72 mm | n/a | n/a | n/a | n/a |
Cash remaining | -445.48 mm | -108.51 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | -13.3 | -9.0 | n/a | n/a | n/a | n/a |
Institutional ownership, Q2 2024
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 171.61 mm |
Total shares | 52.68 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Lord, Abbett & Co. | 50.49 mm | $48.56 mm |
Goldman Sachs & Co | 2.18 mm | $123.04 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Sep 23 | Michael Farrington | Common Stock, par value $0.001 per share | Sale back to company | Dispose D | No | No | 0 | 3,117 | 0.00 | 0 |
1 Sep 23 | Michael Farrington | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,670 | 0.00 | 0 |
1 Sep 23 | Michael Farrington | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,951 | 0.00 | 0 |
1 Sep 23 | Michael Farrington | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 16,405 | 0.00 | 0 |
1 Sep 23 | Michael Farrington | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,670 | 0.00 | 0 |
1 Sep 23 | Michael Farrington | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,219 | 0.00 | 0 |
1 Sep 23 | Michael Farrington | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 1,951 | 0.00 | 0 |
1 Sep 23 | James Christopher Barry | Common Stock, par value $0.001 per share | Sale back to company | Dispose D | No | No | 0 | 72,997 | 0.00 | 0 |
1 Sep 23 | James Christopher Barry | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 45,864 | 0.00 | 0 |
1 Sep 23 | James Christopher Barry | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 38,199 | 0.00 | 0 |